WallStreetZenWallStreetZen

NASDAQ: ACCD
Accolade Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACCD

Based on 7 analysts offering 12 month price targets for Accolade Inc.
Min Forecast
$12.00+38.25%
Avg Forecast
$15.29+76.11%
Max Forecast
$17.00+95.85%

Should I buy or sell ACCD stock?

Based on 7 analysts offering ratings for Accolade Inc.
Strong Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACCD stock forecasts and price targets.

ACCD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-26
lockedlocked$00.00+00.00%2024-01-19
lockedlocked$00.00+00.00%2024-01-09
lockedlocked$00.00+00.00%2024-01-09Find Out Why
lockedlocked$00.00+00.00%2024-01-09
Raymond James
Top 12%
89
BuyMaintains$16.00+84.33%2024-01-09
Stifel Nicolaus
Top 13%
88
Strong BuyMaintains$15.00+72.81%2024-01-04

1 of 1

Forecast return on equity

Is ACCD forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.9%

Forecast return on assets

Is ACCD forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ACCD revenue forecast

What is ACCD's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$493.8M+27.1%
Avg 2 year Forecast
$586.1M+50.88%
Avg 3 year Forecast
$709.5M+82.64%
ACCD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACCD revenue growth forecast

How is ACCD forecast to perform vs Health Information Services companies and vs the US market?
Company
21.76%
Industry
13.39%
Market
10.55%
ACCD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACCD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACCD vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
ACCD$8.68$15.29+76.11%Strong Buy
TALK$3.64$3.00-17.58%Hold
HSTM$24.89N/AN/A
MPLN$0.81N/AN/A
NRC$34.75N/AN/A

Accolade Stock Forecast FAQ

Is Accolade Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: ACCD) stock is to Strong Buy ACCD stock.

Out of 7 analysts, 3 (42.86%) are recommending ACCD as a Strong Buy, 3 (42.86%) are recommending ACCD as a Buy, 1 (14.29%) are recommending ACCD as a Hold, 0 (0%) are recommending ACCD as a Sell, and 0 (0%) are recommending ACCD as a Strong Sell.

If you're new to stock investing, here's how to buy Accolade stock.

What is ACCD's revenue growth forecast for 2025-2027?

(NASDAQ: ACCD) Accolade's forecast annual revenue growth rate of 21.76% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.39%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.55%.

Accolade's revenue in 2024 is $388,486,000.On average, 8 Wall Street analysts forecast ACCD's revenue for 2025 to be $38,222,018,554, with the lowest ACCD revenue forecast at $37,503,985,592, and the highest ACCD revenue forecast at $38,665,099,697. On average, 7 Wall Street analysts forecast ACCD's revenue for 2026 to be $45,371,539,952, with the lowest ACCD revenue forecast at $43,510,815,895, and the highest ACCD revenue forecast at $46,645,823,978.

In 2027, ACCD is forecast to generate $54,924,180,509 in revenue, with the lowest revenue forecast at $54,121,850,662 and the highest revenue forecast at $55,834,106,929.

What is ACCD's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ACCD) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of N/A.

What is ACCD's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ACCD price target, the average ACCD price target is $15.29, with the highest ACCD stock price forecast at $17.00 and the lowest ACCD stock price forecast at $12.00.

On average, Wall Street analysts predict that Accolade's share price could reach $15.29 by Feb 26, 2025. The average Accolade stock price prediction forecasts a potential upside of 76.11% from the current ACCD share price of $8.68.

What is ACCD's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ACCD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.